Sommario
La sindrome poliendocrina autoimmune di tipo 1 è una patologia a trasmissione autosomica recessiva, dovuta alla presenza di mutazioni del gene AIRE. Si caratterizza per la presenza di una triade classica: candidiasi mucocutanea cronica, ipoparatiroidismo cronico e morbo di Addison. A questa triade si possono associare numerose altre patologie autoimmuni e non autoimmuni e la distrofia ectodermica. Questo articolo prende in considerazione le caratteristiche cliniche, genetiche e immunologiche di tale sindrome, con particolare rilievo ai pazienti della popolazione italiana.
Bibliografia
Neufeld M, Blizzard RM (1980) Polyglandular autoimmune disease. In: Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds) Symposium on autoimmune aspects of endocrine disorders. Academic Press, New York, pp 357–365
Betterle C, Presotto F (2008) Autoimmune Polyendocrine Syndromes (APS) or Multiple Autoimmune Syndromes (MAS). In: Walker S, Jara LJ (eds) Handbook of systemic autoimmune diseases, endocrine manifestations of systemic autoimmune diseases. Elsevier, Amsterdam, pp 135–148
Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322:1829–1836
Thorpe ES, Handley HE (1929) Chronic tetany and chronic mycelial stomatitis in a child aged 4 and half years. Am J Dis Child 38:328–338
Sutphin A, Albright F, McCune PJ (1943) Five cases (three in siblings) of idiopathic hypoparathyroidism associated with moniliasis. J Clin Endocrinol Metab 3:625
Betterle C, Greggio NA, Volpato M (1998) Autoimmune polyglandular syndrome (APS) type 1. J Clin Endocrinol Metab 83:1049–1055
Perheentupa J (2006) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 91:2843–2850
Capalbo D, Improda N, Esposito A et al. (2013) Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy from the pediatric perspective. J Endocrinol Invest 36:903–912
Nagamine K, Peterson P, Scott HS et al. (1997) Positional cloning of the APECED gene. Nat Genet 17:393–398
Peterson P, Nagamine K, Scott H et al. (1998) APECED: a monozigenic autoimmune disease providing new clues to self tolerance. Immunol Today 19:384–386
Ferguson BJ, Alexander C, Rossi SW et al. (2008) AIRE’s CARD revealed, a new structure for central tolerance provokes transcriptional plasticity. J Biol Chem 283:1723–1731
Guimaraes WF, Dias-da-Silva MR, Lazaretti-Castro M (2012) Autoimmune polyendocrine syndrome type 1: case report and review of literature. Arq Bras Endocrinol Metabol 56:54–66
Oftedal BE, Hellesen A, Erichsen MM et al. (2015) Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity 42:1185–1196
Meager A, Visvalingam K, Peterson P et al. (2006) Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3:e289
Meloni A, Furcas M, Cetani F et al. (2008) Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 93:4389–4397
Husebye ES, Perheentupa J, Rautemaa R, Kämpe O (2009) Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med 265:514–529
Meloni A, Willcox N, Meager A et al. (2012) Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 97:1114–1124
Perniola R, Falorni A, Clemente MG et al. (2000) Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Eur J Endocrinol 143:497–503
Mazza C, Buzi F, Ortolani F et al. (2011) Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Clin Immunol 139:6–11
Tomar N, Kaushal E, Das M et al. (2012) Prevalence and significance of NALP5 autoantibodies in patients with idiopathic hypoparathyroidism. J Clin Endocrinol Metab 97:1219–1226
Alimohammadi M, Björklund P, Hallgren A et al. (2008) Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358:1018–1028
Cervato S, Morlin L, Albergoni MP et al. (2010) AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED. Clin Endocrinol (Oxf) 73:630–636
Gass JD (1962) The syndrome of keratokonjunctivitis, superficial moniliasis, idiopathic hypoparathyroidism and Addison’s disease. Am J Ophthalmol 54:660–674
Reato G, Morlin L, Chen S et al. (2011) Premature ovarian failure in patients with autoimmune Addison’s disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab 96:E1255–E1261
Dalla Costa M, Bonanni G, Masiero S et al. (2014) Gonadal function in males with autoimmune Addison’s disease and autoantibodies to steroidogenic enzymes. Clin Exp Immunol 176:373–379
Roberts EA (2011) Autoimmune hepatitis from the paediatric perspective. Liver Int 31(19):1424–1431
Scarpa R, Alaggio R, Norberto L et al. (2013) Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 98:704–712
Cetani F, Barbesino G, Borsari S et al. (2001) Novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 86:4747–4752
Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G (2006) Premature mortality in patients with Addison’s disease: a population-based study. J Clin Endocrinol Metab 91:4849–4853
Bensing S, Brandt L, Tabaroj F et al. (2008) Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf) 69:697–704
Erichsen MM, Løvas K, Fougner KJ et al. (2009) Normal overall mortality rate in Addison’s disease, but young patients are at risk of premature death. Eur J Endocrinol 160:233–237
Ringraziamenti
Gli autori ringraziano per la collaborazione nella raccolta e nello studio dei pazienti: Alessandra Cassio (Bologna), Shu Chen (Cardiff), Iacopo Chiodini (Milano), Antonino Crinò (Roma), Giuseppe Delitala (Sassari), Filippo De Luca (Messina), Alessandra Fierabracci (Roma), Jadwiga Furmaniak (Cardiff), Lucia Ghizzoni (Torino), Carla Giordano (Palermo), Roberta Giordano (Torino), Nella Augusta Greggio (Padova), Maria del Pilar Larosa (Cardiff), Luca Manetti (Pisa), Stefano Mariotti (Cagliari), Stefano Masiero (Padova), Patrizia Matarazzo (Torino), Antonella Meloni (Cagliari), Renato Pasquali (Bologna), Roberto Perniola (Lecce), Giuseppe Picca (Foggia), Paolo Porcelli (Palermo), Giorgio Radetti (Bolzano), Bernard Rees Smith (Cardiff), Beatrice Rubin (Padova), Gianni Russo (Milano), Maria Carolina Salerno (Napoli), Giovanna Weber (Milano).
This study was supported in part by the EU Research Project EurAPS: Autoimmune polyendocrine syndrome type I—a rare disorder of childhood as a model for autoimmunity, contract number LSHMCT 2005-005223.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflitto di interesse
Gli autori Corrado Betterle, Monica Salvà, Chiara Sabbadin e Silvia Garelli dichiarano di non avere conflitti di interesse.
Consenso informato
Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.
Studi sugli animali
Gli autori di questo articolo non hanno eseguito studi sugli animali.
Additional information
Proposta da Corrado Betterle.
Materiale elettronico supplementare
I link al materiale elettronico supplementare sono elencati qui sotto.
Rights and permissions
About this article
Cite this article
Betterle, C., Salvà, M., Sabbadin, C. et al. La sindrome poliendocrina autoimmune di tipo 1 in Italia. L'Endocrinologo 17, 10–20 (2016). https://doi.org/10.1007/s40619-016-0169-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40619-016-0169-y